Hong Kong's equity market is showing significant divergence this week. From healthcare and manufacturing firms pivoting aggressively toward AI, to legacy conglomerates grappling with the tail end of traditional economic cycles, this eclectic mix of unclassified stocks reveals where smart money is heading. I'm told that as the current earnings season progresses, investors are increasingly focusing on players capable of translating AI narratives into tangible capacity and commercial orders, leaving traditional valuation models in flux.

Kingboard Holdings (0638.HK)

Kingboard has been outperforming its sector recently, signaling one of the most significant capacity expansions we've seen this year. I'm told the company is making a massive push into AI hardware, attempting to shift from a cyclical materials supplier to a core infrastructure provider for computing power. In June 2026, Kingboard announced plans to raise approximately HKD 11.77 billion through a share placement of its laminates unit. This huge capital injection is earmarked for expanding high-end multi-layer printed circuit board (PCB) and HDI capacity. According to people familiar with the matter, their new Guangdong facility—designed to add 2.5 million square feet of annual capacity—is expected to come online by the first half of 2027, targeting top-tier AI product demand.

Yidu Tech (2158.HK)

On the AI implementation front, Yidu Tech has remained resilient this year. As a dominant player in the clinical research market, the company's core "AI Medical Brain" is actively seeking a breakthrough in the consumer space. In late July 2026, Yidu teamed up with Fudan Zhongshan Hospital to launch a full-cycle weight-loss AI agent. This move is designed to bridge the gap between clinical research, actual treatment, and commercialization. Furthermore, the company is set to distribute a final dividend of HKD 0.04 per share in September, following its upcoming annual general meeting.

Skyworth Group (0752.HK)

Skyworth has faced considerable downward pressure recently. Its net profit for the last fiscal year dropped a steep 27.8% year-over-year to RMB 837 million. This reflects a common predicament for home appliance giants: impairment provisions tied to China's sluggish property market have severely dragged down overall profitability. Still, management is hunting for new growth engines to turn the tide. In early July 2026, Skyworth launched a new AI video game console with Youdu, while its solar PV unit's delisting proposal secured approval in June, potentially clearing the path for future capital restructuring.

MicroPort (0853.HK)

MicroPort's cardiovascular operations have delivered strong results that beat broader expectations. Recent figures show the Endovastec subsidiary generated revenue of USD 189.5 million for the period, up 12.0% year-over-year, alongside a net profit of USD 77.7 million. Against the backdrop of tightening global medical equipment procurement, this suggests its core medical device segment maintains solid counter-cyclical resilience and ongoing profitability.

Also

• CK Hutchison (0001.HK): UBS recently maintained a positive rating and a HKD 101 target price on the diversified conglomerate, indicating that its multinational portfolio remains sturdy enough to weather regional macro headwinds.
• Hong Kong Shanghai Alliance (2431.HK): Its building materials distribution segment bucked industry trends in the latest fiscal year, growing revenue by 1.3% to HKD 1.73 billion, while segment profit jumped a solid 11.5%, showcasing strong cost-control capabilities.
• Weiqiao Textile (2698.HK): As a retrospective note, the legacy cotton producer previously completed its privatization and delisted its H-shares at a premium of over 100%, reflecting ongoing structural overhauls in traditional sectors battling depressed valuations.
• Ruiyuan Intelligent (8549.HK): The CNC machine and smart controller maker continues to navigate the broader industrial automation upgrade cycle, with its core machinery and electronic component sales anchoring cash flows.
• IRC Ltd (2587.HK) and Zhuosheng Enterprise (1682.HK): Both companies have seen minimal operational disclosures or fresh catalysts recently, keeping market attention strictly at a low ebb.

This article does not constitute investment advice.